Millennium Management’s Arcadia Biosciences RKDA Stock Holding History

Millennium Management’s Portfolio RKDA Stock Details RKDA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-10,199	Closed	-$76K	–	6600
2023 Q1	$76K	Buy	10,199 +5,563	+120%	+$59K	﹤0.01%	5507
2022 Q4	$50K	Buy	4,636 +3,783	+443%	+$53.9K	﹤0.01%	5776
2022 Q3	$18K	Buy	853 +223	+35%	+$7.61K	﹤0.01%	6489
2022 Q2	$25K	Buy	+630	New	+$29K	﹤0.01%	6432
2022 Q1	–	Sell	-516	Closed	-$21K	–	7389
2021 Q4	$21K	Buy	+516	New	+$33.6K	﹤0.01%	6597
2021 Q2	–	Sell	-2,226	Closed	-$245K	–	7012
2021 Q1	$245K	Buy	+2,226	New	+$273K	﹤0.01%	5364
2016 Q3	–	Sell	-17	Closed	-$35K	–	3548
2016 Q2	$35K	Buy	+17	New	+$28.4K	﹤0.01%	3090
2015 Q4	–	Sell	-19	Closed	-$46K	–	3723
2015 Q3	$46K	Buy	+19	New	+$79.1K	﹤0.01%	3346

Other funds holding RKDA

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

US Bancorp Minneapolis, Minnesota $82.4B AUM 19.69% 1-Year Est. Return

OLVIG

Oliver Lagore Vanvalin Investment Group Flint, Michigan $255M AUM

Millennium Management's RKDA Position: Q2 2023 in Review

Millennium Management sold out of Arcadia Biosciences (RKDA) in Q2 2023, closing a stake of 10,199 shares — an estimated $76K sold.

Millennium Management first reported a position in RKDA in Q3 2015 and held it in 8 quarters. The position peaked at $245K in Q1 2021. 13 funds tracked by Wall St. Rank hold RKDA as of Q2 2023.

Millennium Management reported no remaining Arcadia Biosciences position as of Q2 2023 after selling out during the quarter.
Millennium Management sold 10,199 Arcadia Biosciences shares in Q2 2023, an estimated $76K.
Millennium Management first reported a position in Arcadia Biosciences in Q3 2015 and held it in 8 quarters.
Millennium Management's Arcadia Biosciences position peaked at $245K in Q1 2021.
13 funds tracked by Wall St. Rank held Arcadia Biosciences as of Q2 2023.

Based on Millennium Management's 13F filing for Q2 2023, filed 14 Aug 2023.